AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate at the 24 th Annual ROTH Conference on March 13 at 4:30 pm PT in Dana Point, CA. Company management will provide an overview of the company followed by a question and answer period with investors. A live webcast of the presentation will be accessible through the Investors section of the Company’s website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until April 13, 2012. About AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit www.amagpharma.com.